• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researcher gets $2.94 million federal grant to study unique features of Ebola and marburg viruses

Bioengineer by Bioengineer
July 15, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Georgia State University

ATLANTA–Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.

“The planned work will help us understand why these viruses are able to cause severe disease and will suggest new approaches for treating these infections,” said Basler, a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis.

Ebola virus and Marburg virus, which belong to the filovirus family, cause periodic outbreaks and severe disease in humans. The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will fund studies that will provide new insight into interactions between filoviruses and hosts related to translation for gene expression and innate immune evasion.

Despite their importance as emerging pathogens and public health threats, many biological aspects of filoviruses remain unknown. One major knowledge gap is the function of the non-protein coding sequences in filovirus genomes, which compose nearly a quarter of the Ebola and Marburg virus genomes and have barely been studied.

Ebola and Marburg viruses are RNA viral pathogens, and it’s unclear which mechanisms are used to translate viral mRNAs to proteins and how this may be sustained when innate immune responses are activated.

###

View an abstract of the grant, 1R01AI148663-01A1, at the NIH’s Project ReRORTer website.

Media Contact
LaTina Emerson
[email protected]

Original Source

https://news.gsu.edu/2020/07/15/biomedical-sciences-researcher-gets-2-94-million-federal-grant-to-study-unique-features-of-ebola-and-marburg-viruses/

Tags: GenesImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Impact of Automated Insulin Therapy on Youth Diabetes Control

October 7, 2025

Researchers Distribute Fitbits to Collect Representative Health Data

October 7, 2025

Plin4 Controls Neuronal Lipid Droplets, Ferroptosis

October 7, 2025

Citrus Aurantium Aromatherapy Alleviates Chemo-Induced Nausea

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    420 shares
    Share 168 Tweet 105
  • New Study Reveals the Science Behind Exercise and Weight Loss

    96 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Automated Insulin Therapy on Youth Diabetes Control

Researchers Distribute Fitbits to Collect Representative Health Data

Physics-Informed Deep Learning Accelerates Agrivoltaic Irradiance Calculations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.